Edition:
United Kingdom

ReShape Lifesciences Inc (RSLS.OQ)

RSLS.OQ on NASDAQ Stock Exchange Capital Market

0.04USD
25 Sep 2018
Change (% chg)

$0.00 (+3.54%)
Prev Close
$0.04
Open
$0.04
Day's High
$0.04
Day's Low
$0.04
Volume
741,257
Avg. Vol
954,501
52-wk High
$38.85
52-wk Low
$0.04

Latest Key Developments (Source: Significant Developments)

Reshape Lifesciences Says NASDAQ Staff Requested Co Submit Plan On/Before Aug 29
Tuesday, 28 Aug 2018 

Aug 28 (Reuters) - ReShape Lifesciences Inc ::RESHAPE LIFESCIENCES - NASDAQ STAFF REQUESTED CO SUBMIT PLAN ON/BEFORE AUG 29, TO ADDRESS STEPS TO ENSURE COMPLIANCE WITH LISTING RULE .  Full Article

Intracoastal Capital Reports 9.99 Pct Passive Stake In Reshape Lifesciences
Friday, 20 Jul 2018 

July 20 (Reuters) - ReShape Lifesciences Inc ::INTRACOASTAL CAPITAL LLC REPORTS 9.99 PERCENT PASSIVE STAKE IN RESHAPE LIFESCIENCES INC AS OF JULY 10, 2018 - SEC FILING.  Full Article

Reshape Lifesciences Says Reshape Balloon Granted Registration By National Health Regulation Authority In Kingdom Of Bahrain
Tuesday, 24 Apr 2018 

April 24 (Reuters) - ReShape Lifesciences Inc ::RESHAPE LIFESCIENCES INC - RESHAPE BALLOON GRANTED REGISTRATION BY NATIONAL HEALTH REGULATION AUTHORITY IN KINGDOM OF BAHRAIN.RESHAPE LIFESCIENCES INC - HAS SIGNED A DISTRIBUTION AGREEMENT WITH YOUSUF MAHMOOD HUSAIN CO W.L.L. OF BAHRAIN.  Full Article

SVLSF IV Reports 14 Pct Passive Stake In Reshape Lifesciences
Friday, 29 Dec 2017 

Dec 29 (Reuters) - Reshape Lifesciences Inc ::SVLSF IV, LLC REPORTS 14 PERCENT PASSIVE STAKE IN RESHAPE LIFESCIENCES AS OF DEC 19 - SEC FILING.  Full Article

Reshape Lifesciences Inc - ‍Received Order For Reshape Integrated Dual Balloon System From Al Zahrawi ​
Wednesday, 13 Dec 2017 

Dec 13 (Reuters) - Reshape Lifesciences Inc ::RESHAPE LIFESCIENCES INC - ‍RECEIVED ORDER FOR RESHAPE INTEGRATED DUAL BALLOON SYSTEM FROM AL ZAHRAWI MEDICAL​.  Full Article

Reshape Lifesciences qtrly loss per share $1.06‍​
Tuesday, 14 Nov 2017 

Nov 14 (Reuters) - Reshape Lifesciences Inc ::Reshape Lifesciences announces third quarter 2017 financial results.Q3 revenue $360,000.Reshape Lifesciences Inc - qtrly loss per share $1.06‍​.  Full Article

UPDATE 1-FDA reports 5 more deaths related to intragastric balloons

June 4 The U.S. Food and Drug Administration on Monday notified healthcare providers that it had received reports of five more deaths in patients using liquid-filled intragastric balloon systems to treat obesity, bringing the total death toll to 12 since 2016.